- Previous Close
12.05 - Open
10.60 - Bid 10.81 x --
- Ask 10.82 x --
- Day's Range
10.80 - 11.73 - 52 Week Range
6.91 - 12.56 - Volume
61,279,441 - Avg. Volume
11,231,686 - Market Cap (intraday)
5.217B - Beta (5Y Monthly) 0.96
- PE Ratio (TTM)
60.00 - EPS (TTM)
0.18 - Earnings Date --
- Forward Dividend & Yield 0.13 (1.31%)
- Ex-Dividend Date Jun 13, 2024
- 1y Target Est
11.09
ChenGuang Biotech Group Co., Ltd. develops and produces natural colors, spice extracts and essential oils, nutritional and pharmaceutical extracts, and oils and protein. The company offers natural colors, including paprika oleoresin, marigold oleoresin, and turmeric; spice extracts and essential oils, such as capsicum oleoresin, sichuan pepper oil, pepper oleoresin, ginger extract, and cumin oil; lutein, lycopene, grape seed extract, curcumin, inulin, stevioside, and green coffee bean extracts; and grape seed oil, walnut oil, safflower seed oil, flaxseed oil, cottonseed oil, natural lutein, and dephenolized cottonseed protein products. Its products are primarily used in food, cosmetics, baking, beverages, health care, and feed industries. The company operates in Europe; the Americas; Australia; China, Russia, Japan, Korea, and other countries in Asia; and Africa. ChenGuang Biotech Group Co., Ltd. was incorporated in 2000 and is based in Quzhou, China.
www.cn-cg.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 300138.SZ
View MorePerformance Overview: 300138.SZ
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300138.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300138.SZ
View MoreValuation Measures
Market Cap
5.82B
Enterprise Value
8.94B
Trailing P/E
66.28
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.89
Price/Book (mrq)
1.87
Enterprise Value/Revenue
1.28
Enterprise Value/EBITDA
23.03
Financial Highlights
Profitability and Income Statement
Profit Margin
2.16%
Return on Assets (ttm)
2.57%
Return on Equity (ttm)
3.44%
Revenue (ttm)
6.93B
Net Income Avi to Common (ttm)
149.87M
Diluted EPS (ttm)
0.18
Balance Sheet and Cash Flow
Total Cash (mrq)
2.55B
Total Debt/Equity (mrq)
129.94%
Levered Free Cash Flow (ttm)
49.06M